Newsroom | 4526 results

ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the successful administration of its first GLP-1 (exenatide) implant in the LIBERATE-1™ clinical trial. This milestone marks a critical step toward addressing one of healthcare’s most pressing challenges: medication adherence in metabolic diseases including chronic weight management an...

DURHAM, N.C.--(BUSINESS WIRE)--The Emily Program, a nationally recognized leader in eating disorder specialty care and behavioral health services, today announced an expansion of care that fills a critical gap in eating disorder treatment for patients with diabetes. The Diabetes and Eating Disorder Management Program, exclusively offered in The Emily Program’s Durham, North Carolina center, creates a pathway to recovery for this at-risk population and reduces the scarcity of eating disorder tre...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--The Heart & Kidney Community Health Screening offers free Lp(a) testing as well as screenings for other related metabolism and kidney risks....

DUBLIN--(BUSINESS WIRE)--The "Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region" report has been added to ResearchAndMarkets.com's offering. The global liraglutide and semaglutide market accounted for USD 15.87 billion in 2023 and is expected to reach USD 51.83 billion by 2034 with a CAGR of 11.36% during the forecast period 2024-2034. The market will grow due to factors such as the increasing prevalence of type 2 diab...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that AlloSure® is now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. Both indicatio...

PLANTATION, Fla.--(BUSINESS WIRE)--NationsBenefits®, the leading supplemental benefits and healthcare fintech solutions provider, is proud to announce its partnership with TS Emporium, a trusted provider of Asian-focused food, wellness, and household products. This partnership brings health plan members unprecedented access to culturally relevant products through the NationsBenefits Marketplace and enhances its Over-the-Counter (OTC) grocery benefit offerings with authentic Asian products desig...

GENÈVE et NEW YORK--(BUSINESS WIRE)--À la veille d’une étape importante des Nations unies, l’industrie pharmaceutique mondiale a lancé un « appel à l’action » pour inciter à une action collective dans le monde entier afin de lutter contre l’augmentation des maladies non transmissibles (MNT) telles que le cancer, le diabète, les maladies cardiovasculaires, les maladies pulmonaires, la santé mentale et les troubles neurologiques. Les MNT sont responsables de près de 75 % des décès dans le monde....

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company's global headquarters in Acton, Massachusetts on Thursday, June 5, 2025. Presentations will be led by Jim Hollingshead, President and CEO, members of the Executive Leadership Team, and independent experts. The agenda will include a comprehensive overview of the Company’s lea...

GINEVRA E NEW YORK--(BUSINESS WIRE)--In vista di questo importante appuntamento delle Nazioni Unite, l'industria farmaceutica mondiale ha pubblicato un "Invito ad agire" per sollecitare un'azione collettiva in tutto il mondo per affrontare l'aumento delle malattie croniche non trasmissibili (MCNT) come cancro, diabete, malattie cardiovascolari, malattie polmonari, malattie mentali e disturbi neurologici. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione u...

GENEVA & NEW YORK--(BUSINESS WIRE)--Vooruitlopend op een belangrijke mijlpaal van de VN, heeft de internationale farmaceutische industrie een “Oproep tot Actie” gelanceerd, waarin wordt aangedrongen op collectieve actie over de hele wereld om de stijging van niet-overdraagbare ziekten zoals kanker, diabetes, cardiovasculaire aandoeningen, longaandoeningen, geestelijke gezondheidsproblemen en neurologische stoornissen tegen te houden. Deze bekendmaking is officieel geldend in de originele bronta...